Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
Nat Biotechnol. 2024 Oct;42(10):1526-1537. doi: 10.1038/s41587-023-02078-y. Epub 2024 Jan 8.
Prime editing enables precise installation of genomic substitutions, insertions and deletions in living systems. Efficient in vitro and in vivo delivery of prime editing components, however, remains a challenge. Here we report prime editor engineered virus-like particles (PE-eVLPs) that deliver prime editor proteins, prime editing guide RNAs and nicking single guide RNAs as transient ribonucleoprotein complexes. We systematically engineered v3 and v3b PE-eVLPs with 65- to 170-fold higher editing efficiency in human cells compared to a PE-eVLP construct based on our previously reported base editor eVLP architecture. In two mouse models of genetic blindness, single injections of v3 PE-eVLPs resulted in therapeutically relevant levels of prime editing in the retina, protein expression restoration and partial visual function rescue. Optimized PE-eVLPs support transient in vivo delivery of prime editor ribonucleoproteins, enhancing the potential safety of prime editing by reducing off-target editing and obviating the possibility of oncogenic transgene integration.
先导编辑可在活系统中精确地进行基因组替换、插入和缺失。然而,高效的体外和体内递呈先导编辑组件仍然是一个挑战。在这里,我们报告了先导编辑器工程病毒样颗粒(PE-eVLPs),可将先导编辑蛋白、先导编辑向导 RNA 和切口单引导 RNA 作为瞬时核糖核蛋白复合物递呈。与我们之前报道的基于碱基编辑器 eVLP 结构的 PE-eVLP 构建体相比,我们系统地工程化了 v3 和 v3b PE-eVLPs,在人类细胞中的编辑效率提高了 65-170 倍。在两种遗传性失明的小鼠模型中,单次注射 v3 PE-eVLPs 可使视网膜中达到治疗相关水平的先导编辑、蛋白表达恢复和部分视觉功能挽救。优化后的 PE-eVLPs 支持体内瞬时递呈先导编辑核糖核蛋白,通过减少脱靶编辑和避免致癌转基因整合的可能性,提高了先导编辑的潜在安全性。